Renal transplantation: Origins and future

International Surgery

Volumn 84, Issue 4, 1999, Pages 291-296

  Talbot, David ^a  

^a Department of Surgery ^*  (United Kingdom)

Author keywords

Immunosuppression; Organ donation; Renal transplantation

Indexed keywords

ANIMAL; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; REVIEW; TRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT;

EID: 0033202675     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Merrill J, Murray J, Harrison H, Guild W. Successful homotransplantation of the human kidney between identical twins. JAMA 1956; 160: 277-82
2. Kolff W, Berk H. The artificial kidney: a dialyser with a great area. Acta Med Scand 1944; 117: 121-34
3. Carrel A, Guthrie C. Anastomosis of blood vessels by the patching method and transplantation of the kidney. JAMA 1906; 48: 1648-50
4. Pleass H, Clark K, Rigg K, Reddy K, Forsythe JLR. Urological complications after renal transplantation. Transplant Proc 1995; 27: 1091-2
5. Kelly W, Lillehei R, Merkel FK, Idezuki T, Goetz F. Allotransplantation of the pancreas and duodenum along with kidney in diabetic nephropathy. Surgery 1967; 61: 827-31
6. Gagnadoux M, Niaudet P, Broyer M. Non-immunological risk factors in paediatric renal transplantation. Paediatr Nephrol 1993; 7: 89-95
7. Abusin K, Rix D, Mohammed M, Bawa S, Talbot D, Manas D et al. Long-term adult renal graft outcome after ureteric drainage into an augmented bladder or ileal conduit. Transplant Int 1998; 11 (Suppl 1): 147-9
8. Ruiz Alvarez de Cienfuegos F. Kidney transplantation in patients with urinary diversion or with anomalies of the lower urinary tract. Arch Esp Urol 1996; 49: 1101-6
9. Talbot D, Narasimhan K, Mirza D, Thick M, Manas D. More paediatric renal donors should be used for adult recipients. BMJ 1996; 313: 303
10. Ratner L, Cigarro F, Bender J, Magnuson T, Krauss E. Transplantation of single and paired paediatric kidneys into adult recipients. J Am Coll Surg 1997; 185: 437-45
11. Dafoe D, Alfrey E. Dual renal grafts: expansion of the donor pool from an overlooked source. Transplant Int 1998; 11: 164-8
12. Balupuri S, Abusin K, Gerstenkorn C, Manas D, Talbot D. Expansion of donor pool: lack of function predictors. Transplant Int 1999; 12: 158
13. Nicholson M, Bradley J. Renal transplantation from living donors. BMJ 1999; 318: 409-10
14. Merrill J, Murray J, Harrison J, Friedman E, Dealy J, Dammin G. Successful homotransplantation of the kidney between non identical twins. N Engl J Med 1960; 262: 1251-63
15. Kuss R, Legrain M, Mathe G, Nedey R, Camey M. Homologous human kidney transplantation. Experience with six patients. Postgrad Med J 1962; 38: 528-31
16. Calne R, Murray J. Inhibition of the rejection of renal homografts in dogs by Burroughs Welcome 57-32. Surg Forum 1961; 12: 118-20
17. Merrill J, Murray J, Takacs F, Hager E, Wilson R, Dammin G. Successful transplantation of a kidney from a human cadaver. JAMA 1963; 185: 347-53
18. Murray J, Merrill J, Harrison J, Wilson R, Dammin G. Prolonged survival of human kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963; 268: 1315-23
19. Ellis L, Lawson R, Kircheim D, Hodges C. Effect of antilymphocyte serum on canine renal homotransplantation. J Urol 1967; 97: 804-10
20. Borel J, Feurer C, Magnee D, Stahelin H. Effect of the new antilymphocytic peptide cyclosporin A in animals. Immunology 1977; 32: 1017-25
21. Calne R, White D, Rolles K, Smith D, Herbertson B. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet 1978; 1: 1183-5
22. Kobashigawa J, Renlund D, Olsen S. Initial results of RS-61443 for refractory cardiac rejection. J Am Coll Cardiol 1992; 19: 203A
23. Cosimi A, Burton R, Colvin R, Goldstein G, Delmonico F, LaQuaglia M et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981; 32: 535-9
24. Nashan B, Moore R, Amlot P, Schmidt A, Abeywickrama K, Soulillou J. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997; 350: 1193-8
25. Chahine AA, Yu M, McKernan M, Stoeckert C, Linsley PS, Lau HT. Local CTLA4Ig synergizes with one-dose anti-LFA-1 to achieve long-term acceptance of pancreatic islet allografts. Transplant Proc 1994; 26: 3296
26. Hale G, Bright S, Chumbley G, Hoang T, Metcalfe D, Munro A, et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873-82
27. Hourmant M, Bedrossian J, Durand D. A randomized multi center trial comparing LFA-1 monoclonal antibody with rabbit anti-thymocyte globulin as induction treatment in first kidney transplantation. Transplantation 1996; 62: 1565-70
28. Cecka J, Cho Y, Terasaki P. Analysis of the UNOS scientific renal transplant registry at three years-early events affecting transplant success. Transplantation 1992; 53: 59-64
29. Opelz G, Henderson G. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-6
30. Opelz G. Effect of the maintenance immunosuppressive drug regime on kidney outcome. Transplantation 1994; 58: 443-6
31. Zhang J, Walmsley M, Moy J, Talbot D, Dark J, Kirby J. Differential effects of cyclosporin A and tacrolimus on TGF-B production. Transplant Int 1998; 11 (Suppl): 325-7
32. Calne R. Wofie hypothesis: some thoughts on an approach toward allograft tolerance. Transplant Proc 1996; 28: 1152
33. Meyers K, Thomson P, Weiland H. Non compliance in children and adolescents after renal transplantation. Transplantation 1996; 62: 186-9
34. Siegal B, Greenstein S. Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. Adv Ren Replace Ther 1997; 4: 46-54
35. Dunn J, Golden D, van Buren C, Lewis R, Lawen J, Kahan B. Causes of graft loss beyond two years in the cyclosporin era. Transplantation 1990; 49: 349-53
36. Sheill AGR. Patterns of malignancies following renal transplantation. Transplant Proc 1999; 31: 263-5
37. Riddler S, Breinig M, McKnight J. Increased levels of circulating Epstein-Barr virus (EBV) infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients. Blood 1994; 84: 972-84
38. Savage P, Waxman J. Post-transplantation lymphoproliferative disease. Q J Med 1997; 90: 497-503
39. Swinnen L, Mullen G, Carr T, Costanzo M, Fisher R. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 86: 3333-40
40. Rooney C, Smith C, Ng C. Use of gene-modified virus specific T lymphocyte to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995; 345: 9-13
41. Gerstenkorn C, Jackson G, Manas D, Talbot D. What happens to kidney and liver allograft recipients who develop post-transplant lymphoproliferative disorders? Transplantation (Submitted)
42. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyper-acute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966: 1: 662-5
43. Terasaki P, McLelland J. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000
44. Lucas Z, Coplon N, Kempson R, Cohn R. Early renal transplant failure associated with subliminal sensitisation. Transplantation 1970; 10: 522-9
45. Nelken D, Cohen I, Furcaig I. A method to increase the sensitivity of the lymphocyte microcytotoxicity test. Transplantation 1970; 10: 346-7
46. Talbot D. The flow cytometric crossmatch in perspective. Transplant Immunol 1993; 1: 155-62
47. Dyer P, Martin S, Sinnott P. Histocompatibility testing for kidney transplantation: an update. Nephrol Dial Transplant 1995; 10 (Suppl 1): 23-8
48. Ogura K, Terasaki P, Johnson C, Mendez R, Rosenthal J, Ettenger R et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993; 56: 294-8
49. Martin S, Taylor C. The immunologically sensitised renal transplant recipient: the impact of advances in technology on organ allocation and transplant outcome. Transplant Rev 1999; 13: 40-51
50. van Rood J, Lagaaij E, Doxiadis I. Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making. Los Angeles: UCLA Tissue Typing Laboratory, 1993
51. Thiel G. Living kidney donor transplantation - new dimensions. Transplant Int 1998; 11 (Suppl 1): 550-6
52. Dunlop P, Varty K. Non heart beating donors: the Leicester experience. Transplant Proc 1995; 27: 2940-1
53. Kootstra G. Statement on non-heart beating donor programmes. Transplant Proc 1995; 27: 2965
54. Daemen J, Oomen A, Janssen M, van de Schoot L, van Kreel B, Heineman E et al. Glutathione S-transferase as predictor of functional outcome in transplantation of machine preserved non-heart-beating donor kidneys. Transplantation 1997; 63: 89-93
55. Balupuri S, Buckley P, Snowden C, Sen B, Griffiths P, Hannon M et al. The trouble with kidneys derived from the non heart beating donor: a single centre 10 year experience. Transplantation 1999; In press
56. White D. Alteration of complement, activity: a strategy for xenotransplantation. Trends Biotechnol 1996; 14: 3-5
57. Zaidi A, Schmoeckel M, Bhatti F, Waterworth P, Tolan M, Cozzi E et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584-90